EEGLE by CortexXus
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 10/16/2019
Pipeline Type
New Diagnostic Tools
Phase Of Development
N/A
Sponsors and Collaborators
CortexXus
Mechanism of Action
Mechanism Description
Long-Term Ambulatory EEG
Populations Tested In
Epilepsy
Other Resources
Special FDA Designation
Nonprofit or Government Support
Government
Nonprofit or Government Support Description
NSF I-Corp
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link